Vascular Access News

Using regional anesthesia for patients undergoing arteriovenous fistula creation for dialysis access conferred better patency outcomes at 1 year compared with local anesthesia, according to a recently published study.

Published findings indicated that while patients 77 years or older had lower likelihoods of arteriovenous fistula placement and maturation, those who experienced maturation did not have greater rates of patency loss than younger patients.

A retrospective study conducted in Belgium found neither catheter nor arteriovenous access was associated with survival in patients on hemodialysis.

The FDA has granted breakthrough device designation to Laminate Medical’s tool for the creation of arteriovenous fistulas in patients on hemodialysis, according to a company press release.

Study findings indicated that although most patients who had insurance before developing end-stage renal disease initiate hemodialysis with a central venous catheter, use of fistula for vascular access demonstrated the lowest risk for subsequent bloodstream infections.

The radiocephalic fistula yielded the best post-intervention primary patency rates when compared to brachiocephalic fistula and brachiobasilic fistula, according to study results reported in Kidney Medicine.

Buttonhole cannulation is associated with a higher risk for vascular access-related infection than rope-ladder cannulation in patients on in-center hemodialysis, according to a published study.

The National Kidney Foundation has released the latest Kidney Disease Outcomes Quality Initiative Clinical Practice Guideline for Vascular Access.

The FDA has granted a de novo classification order to Bluegrass Vascular Technologies for its Surfacer Inside-Out Access Catheter System. The device was designed to enable central venous access in patients with venous obstructions, according to a press release.

KANSAS CITY, Mo. — The buttonhole technique for vascular access is safe for home hemodialysis as long as patients are diligent about skin preparation and cannulation, clinicians from Fresenius Medical Care reported in a poster presentation.